In Part 1, we covered how fat gets released from storage and transported into the mitochondria. But none of that matters if the mitochondria can’t process it efficiently. Fat loss doesn’t happen in your bloodstream. It happens inside the mitochondria tiny power plants in your cells that turn fuel into energy. Once fatty acids are delivered, they enter a multi-step process that converts them into ATP. This is where the real “burning” of fat happens. It’s called beta-oxidation and it’s tightly controlled by mitochondrial structure, function, and demand.
Once inside the mitochondria, fatty acids are broken down into acetyl-CoA units through beta-oxidation. These units then enter the Krebs cycle, producing electrons that are shuttled through the electron transport chain (ETC). The final product is ATP...our cellular energy. But this entire chain only runs efficiently when the mitochondria are healthy, active, and responsive to your body’s energy needs.
This is where mitochondrial dynamics come into play. Your mitochondria aren’t static they’re constantly undergoing fusion (joining together) and fission (splitting apart) to adapt to energy demand, remove damaged parts, and increase their functional capacity. Fusion supports energy efficiency by creating large, interconnected networks that can share components and optimize ATP production. Fission allows damaged mitochondria to be isolated and removed through mitophagy a quality control process. If this balance is off, you lose energy efficiency, generate more oxidative stress, and impair fat oxidation.
You also need strong membrane potential the electrochemical gradient across the inner mitochondrial membrane. This gradient is what drives ATP synthesis. If membrane potential is low, the mitochondria struggle to process fatty acids, and beta-oxidation slows down. If it’s too high and uncoupling doesn’t occur, oxidative stress can build.
Now, let's talk about how to support this phase, oxidizing fat inside the mitochondria through targeted interventions that improve mitochondrial efficiency, quality, and turnover. We have several tools, SLU-PP-332 is a powerful compound that acts as an agonist of ERRα (Estrogen-Related Receptor Alpha), a nuclear receptor that regulates genes involved in oxidative metabolism, mitochondrial biogenesis, and fatty acid oxidation. SLU increases the transcription of proteins responsible for beta-oxidation and oxidative phosphorylation, making the mitochondria more efficient and flexible in using fat as fuel. It also synergizes with AMPK and PGC-1α signaling, reinforcing the adaptation to fat as a primary fuel source. Urolithin A enhances mitophagy, the recycling of dysfunctional mitochondria. As you push your metabolism with fasting, training, or caloric deficits, mitochondrial stress increases. Urolithin A clears out damaged mitochondria and promotes the growth of newer, more efficient ones. This keeps the beta-oxidation machinery clean and fully operational, especially during extended fat loss phases.
SS-31 (Elamipretide) is a mitochondrial-targeted peptide that binds to cardiolipin, a key phospholipid on the inner mitochondrial membrane. Cardiolipin helps maintain the shape and integrity of cristae—the folds in the membrane where the electron transport chain operates. By protecting cardiolipin, SS-31 preserves membrane potential, improves ATP production, and reduces oxidative damage. This makes it easier for mitochondria to burn fat efficiently without excessive stress. CoQ10 plays a direct role in the electron transport chain. It shuttles electrons between complexes and supports ATP synthesis. During fat oxidation, high amounts of electrons are produced. CoQ10 ensures they’re handled efficiently, minimizing electron leakage and oxidative stress. PQQ (Pyrroloquinoline quinone) supports mitochondrial biogenesis the process of making new mitochondria. With more mitochondria, your body can burn more fat at once. It also reduces mitochondrial inflammation and enhances NAD+ cycling, which supports overall energy production.
Zone 2 cardio continues to play a key role here. It increases mitochondrial density and trains your body to use fat more efficiently at rest and during activity. It keeps the mitochondria in a state of sustained demand without generating high levels of reactive oxygen species or stressing recovery systems.
Red light therapy improves cytochrome c oxidase activity, enhances membrane potential, and stimulates mitochondrial repair. When used consistently, it boosts mitochondrial readiness and makes beta-oxidation more efficient, especially in conjunction with other interventions like fasting, carnitine, or uncouplers. BAM15, while introduced in Part 1, really shines here. As a mitochondrial uncoupler, it increases the leak of protons across the inner mitochondrial membrane. This makes the mitochondria burn more fuel to maintain ATP levels. The result: increased fat oxidation without stimulating the nervous system. It’s a clean way to increase energy expenditure, but it should be used with care and only in specific scenarios. Remeber NOT to take it with SLU.
In summary, this phase is about efficiency. It’s not enough to get fat into the mitochondria—it has to be processed well, consistently, and with minimal collateral damage. That means supporting mitochondrial structure, redox balance, and turnover.
In Part 3, we’ll look at how your body decides which fuel to burn fat or sugar and how you can influence that decision through hormones, nutrient timing, and specific compounds that bias the system toward fat oxidation. This is where AMPK, mTOR, PPARs, and ERRs really start to shape the long-term fat loss game.